Literature DB >> 17941081

Activation or inactivation of cardiac Akt/mTOR signaling diverges physiological from pathological hypertrophy.

Ole Johan Kemi1, Marcello Ceci, Ulrik Wisloff, Serena Grimaldi, Paolo Gallo, Godfrey L Smith, Gianluigi Condorelli, Oyvind Ellingsen.   

Abstract

Cardiomyocyte hypertrophy differs according to the stress exerted on the myocardium. While pressure overload-induced cardiomyocyte hypertrophy is associated with depressed contractile function, physiological hypertrophy after exercise training associates with preserved or increased inotropy. We determined the activation state of myocardial Akt signaling with downstream substrates and fetal gene reactivation in exercise-induced physiological and pressure overload-induced pathological hypertrophies. C57BL/6J mice were either treadmill trained for 6 weeks, 5 days/week, at 85-90% of maximal oxygen uptake (VO(2max)), or underwent transverse aortic constriction (TAC) for 1 or 8 weeks. Total and phosphorylated protein levels were determined with SDS-PAGE, and fetal genes by real-time RT-PCR. In the physiologically hypertrophied heart after exercise training, total Akt protein level was unchanged, but Akt was chronically hyperphosphorylated at serine 473. This was accompanied by activation of the mammalian target of rapamycin (mTOR), measured as phosphorylation of its two substrates: the ribosomal protein S6 kinase-1 (S6K1) and the eukaryotic translation initiation factor-4E binding protein-1 (4E-BP1). Exercise training did not reactivate the fetal gene program (beta-myosin heavy chain, atrial natriuretic factor, skeletal muscle actin). In contrast, pressure overload after TAC reactivated fetal genes already after 1 week, and partially inactivated the Akt/mTOR pathway and downstream substrates after 8 weeks. In conclusion, changes in opposite directions of the myocardial Akt/mTOR signal pathway appears to distinguish between physiological and pathological hypertrophies; exercise training associating with activation and pressure overload associating with inactivation of the Akt/mTOR pathway. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17941081     DOI: 10.1002/jcp.21197

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  89 in total

Review 1.  A systematic comparison of exercise training protocols on animal models of cardiovascular capacity.

Authors:  Rui Feng; Liyang Wang; Zhonguang Li; Rong Yang; Yu Liang; Yuting Sun; Qiuxia Yu; George Ghartey-Kwansah; Yanping Sun; Yajun Wu; Wei Zhang; Xin Zhou; Mengmeng Xu; Joseph Bryant; Guifang Yan; William Isaacs; Jianjie Ma; Xuehong Xu
Journal:  Life Sci       Date:  2018-12-03       Impact factor: 5.037

2.  β2-Adrenergic receptor signaling in the cardiac myocyte is modulated by interactions with CXCR4.

Authors:  Thomas J LaRocca; Martina Schwarzkopf; Perry Altman; Shihong Zhang; Achla Gupta; Ivone Gomes; Zikiar Alvin; Hunter C Champion; Georges Haddad; Roger J Hajjar; Lakshmi A Devi; Alison D Schecter; Sima T Tarzami
Journal:  J Cardiovasc Pharmacol       Date:  2010-11       Impact factor: 3.105

3.  MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice.

Authors:  Denghong Zhang; Riccardo Contu; Michael V G Latronico; Jianlin Zhang; Jian Ling Zhang; Roberto Rizzi; Daniele Catalucci; Shigeki Miyamoto; Katherine Huang; Marcello Ceci; Yusu Gu; Nancy D Dalton; Kirk L Peterson; Kun-Liang Guan; Joan Heller Brown; Ju Chen; Nahum Sonenberg; Gianluigi Condorelli
Journal:  J Clin Invest       Date:  2010-07-19       Impact factor: 14.808

Review 4.  Mechanisms of Cardiac Repair and Regeneration.

Authors:  Kathleen M Broughton; Bingyan J Wang; Fareheh Firouzi; Farid Khalafalla; Stefanie Dimmeler; Francisco Fernandez-Aviles; Mark A Sussman
Journal:  Circ Res       Date:  2018-04-13       Impact factor: 17.367

5.  Ivabradine improved left ventricular function and pressure overload-induced cardiomyocyte apoptosis in a transverse aortic constriction mouse model.

Authors:  Yihui Yu; Zuoying Hu; Bing Li; Zhimei Wang; Shaoliang Chen
Journal:  Mol Cell Biochem       Date:  2018-05-22       Impact factor: 3.396

Review 6.  AKT signalling in the failing heart.

Authors:  Antoine H Chaanine; Roger J Hajjar
Journal:  Eur J Heart Fail       Date:  2011-06-30       Impact factor: 15.534

Review 7.  Myocardial AKT: the omnipresent nexus.

Authors:  Mark A Sussman; Mirko Völkers; Kimberlee Fischer; Brandi Bailey; Christopher T Cottage; Shabana Din; Natalie Gude; Daniele Avitabile; Roberto Alvarez; Balaji Sundararaman; Pearl Quijada; Matt Mason; Mathias H Konstandin; Amy Malhowski; Zhaokang Cheng; Mohsin Khan; Michael McGregor
Journal:  Physiol Rev       Date:  2011-07       Impact factor: 37.312

8.  Genome-wide analysis of histone marks identifying an epigenetic signature of promoters and enhancers underlying cardiac hypertrophy.

Authors:  Roberto Papait; Paola Cattaneo; Paolo Kunderfranco; Carolina Greco; Pierluigi Carullo; Alessandro Guffanti; Valentina Viganò; Giuliano Giuseppe Stirparo; Michael V G Latronico; Gerd Hasenfuss; Ju Chen; Gianluigi Condorelli
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-27       Impact factor: 11.205

9.  Uric acid promotes left ventricular diastolic dysfunction in mice fed a Western diet.

Authors:  Guanghong Jia; Javad Habibi; Brian P Bostick; Lixin Ma; Vincent G DeMarco; Annayya R Aroor; Melvin R Hayden; Adam T Whaley-Connell; James R Sowers
Journal:  Hypertension       Date:  2014-12-08       Impact factor: 10.190

Review 10.  Molecular discoveries and treatment strategies by direct reprogramming in cardiac regeneration.

Authors:  John H Werner; John H Rosenberg; John Y Um; Michael J Moulton; Devendra K Agrawal
Journal:  Transl Res       Date:  2018-07-31       Impact factor: 7.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.